Veloxis Pharmaceuticals, Inc. - Exhibitor



Company Website

Contact Information:

Myriam Alfonso
mal@veloxis.com
786-479-4203

Caroline Berlinger
cmb@veloxis.com
215-385-1110

 

Virtual Exhibit Hall Home

 

Veloxis Pharmaceuticals A/S, an Asahi Kasei company, is a commercial-stage specialty pharmaceutical company committed to improving the lives of transplant patients. Veloxis Pharmaceuticals A/S operates in the U.S. through Veloxis Pharmaceuticals, Inc., a wholly owned subsidiary headquartered in Cary, North Carolina, USA. Veloxis is focused on the direct commercialization of immunosuppression medications in the US, expansion of partnerships for markets around the world, and acquisition of assets utilized in transplant patients and by adjacent medical specialties.

Additional Information:
Rapid Metabolizers of Tacrolimus

Veloxis Transplant Support Program 

How Veloxis Helps My Patients?